News

October 24-26, 2025: EosDx Team Attends the 6th Annual Santa Monica Cancer Conference
September 16th, 2025: San Antonio Breast Cancer Symposium abstract accepted for presentation
February 6, 2025: Initiation of First In-Human Trial at Valley Breast Care, CA Marks Key Milestone for EosDx
October 28, 2024: Howard Maibach MD, Joins The Clinical Advisory Board
October 5, 2024: Dr. Rachel Brem: Breakthrough Women In Science & Medicine
September 25, 2024: Louise Jones PhD Joins The Scientific Advisory Board
September 20, 2024: Prashant Chawla, MD Joins The Clinical Advisory Board
September 1, 2024: David de Weese, Appointed As CEO
August 29, 2024: Thomas Lomis MD, Joins The Clinical Advisory Board
April 8, 2024: Arturas Vailionis PhD, Joins The Scientific Board
January 4, 2024: Lev Murokh, Joins The Scientific Advisory Board
October 6, 2022: Rachel Brem MD, Joins The Board Of Directors
May 12, 2022: John Pavlidis, Joins As President & CEO, And Board Member
May 12, 2022: Series seed round of $6m raised
December 23, 2021: Marilyn Simons PhD, Joins The Board Of Directors
November 3, 2020: Pioneering Non-Invasive Breast Biopsy – A. Lazarev
September 1, 2020: Addressing The 80 Percent
March 5, 2020: Professor Mark Pegram MD, Joins The Clinical Advisory Board
February 4, 2020: Byron Aram MD, Joins As Chief Medical Officer
January 15, 2020: Charlene Greenwood PhD, Joins The Scientific Advisory Board
January 15, 2020: Keith Rogers PhD, Joins The Scientific Advisory Board
November 15, 2019: David de Weese, Joins Board Of Directors